Flow Neuroscience has invented a new, medication-free treatment for depression, comprised of a brain stimulation headset and therapy app.
The company's implantable system is the only long-term CGM that lasts up to 90 days; it is now available for $99 plus the cost of the sensor placement.
The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
Under the deal, Orion's existing line of Easyhaler products will connect to Propeller's digital medicine platform via a small, custom-built sensor.
The filing describes a device with an array of sensors that would be able to reduce or stabilize involuntary movement in an adjacent joint or entire limb.
Adding reSET to outpatient therapy significantly improved abstinence in substances of abuse and treatment retention compared to standard of care alone.
It is a work of the researchers at the University of California at Berkeley's Radiology & Biomedical Imaging Department and the Big Data in Radiology group.
The OneTouch Reveal mobile app can now spot recurring high or low patterns and automatically notify users so they can take action to avoid them in the future.
The engine at the heart of this category is four pillars called AI+AI, which is the acronym for Aggregate, Interpret, Apply, and Iterate.
The hub enables healthcare workers, patients, carers, charities and researchers to find the information most relevant to them at their fingertips.